| 000 | 01863 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516155255.0 | ||
| 264 | 0 | _c20151006 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1537-453X | ||
| 024 | 7 |
_a10.1097/COC.0b013e31829d1eb8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArsenault, Daniel | |
| 245 | 0 | 0 |
_aPredictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cAug 2015 |
||
| 300 |
_a348-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Nodes _xpathology |
| 650 | 0 | 4 | _aMastectomy |
| 650 | 0 | 4 | _aMastectomy, Segmental |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aHurley, Judith | |
| 700 | 1 | _aTakita, Cristiane | |
| 700 | 1 | _aReis, Isildinha M | |
| 700 | 1 | _aZhao, Wei | |
| 700 | 1 | _aRodgers, Steven | |
| 700 | 1 | _aWright, Jean L | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 38 _gno. 4 _gp. 348-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/COC.0b013e31829d1eb8 _zAvailable from publisher's website |
| 999 |
_c22865145 _d22865145 |
||